Gilead Sciences Inc. (GILD) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
333 LAKESIDE DR FOSTER CITY, CA 94404 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,179 | 6,385 | 6,520 | 7,408 | 24,352 | 30,089 | |||
| Cash and cash equivalents | 5,412 | 5,338 | 5,997 | 11,631 | 17,940 | ||||
| Short-term investments | 1,179 | 973 | 1,182 | 1,411 | 12,721 | 12,149 | |||
| Receivables | 4,660 | 4,777 | 4,493 | 4,901 | 3,582 | 3,327 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,787 | 1,507 | 1,618 | 1,683 | 922 | 814 | |||
| Inventory | 1,787 | 1,507 | 1,618 | 1,683 | 922 | 814 | |||
| Other undisclosed current assets | 8,459 | 1,774 | 2,141 | 2,004 | 1,440 | 1,606 | |||
| Total current assets: | 16,085 | 14,443 | 14,772 | 15,996 | 30,296 | 35,836 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 5,317 | 5,475 | 5,121 | 4,967 | 4,502 | 4,006 | |||
| Long-term investments and receivables | 1,163 | 1,245 | 1,309 | 502 | 1,488 | 1,423 | |||
| Long-term investments | 1,163 | 1,245 | 1,309 | 502 | 1,488 | 1,423 | |||
| Intangible assets, net (including goodwill) | 34,768 | 37,208 | 41,787 | 41,234 | 17,903 | 19,855 | |||
| Goodwill | 8,314 | 8,314 | 8,332 | 8,108 | 4,117 | 4,117 | |||
| Intangible assets, net (excluding goodwill) | 26,454 | 28,894 | 33,455 | 33,126 | 13,786 | 15,738 | |||
| Other noncurrent assets | 4,792 | 4,800 | 4,963 | 5,708 | 7,438 | 2,555 | |||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 46,040 | 48,728 | 53,180 | 52,411 | 31,331 | 27,839 | |||
| TOTAL ASSETS: | 62,125 | 63,171 | 67,952 | 68,407 | 61,627 | 63,675 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 550 | 905 | 6,850 | 5,180 | 3,787 | 3,929 | |||
| Accounts payable | 550 | 905 | 705 | 844 | 713 | 790 | |||
| Accrued liabilities | 6,145 | 4,336 | 3,074 | 3,139 | |||||
| Debt | 1,798 | 2,273 | 1,516 | 2,757 | 2,499 | 2,748 | |||
| Other liabilities | 5,130 | 4,580 | |||||||
| Other undisclosed current liabilities | 3,802 | 3,479 | 3,244 | 3,460 | 3,473 | 3,928 | |||
| Total current liabilities: | 11,280 | 11,237 | 11,610 | 11,397 | 9,759 | 10,605 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 23,189 | 22,957 | 25,179 | 28,645 | 22,094 | 24,574 | |||
| Long-term debt, excluding current maturities | 23,189 | 22,957 | 25,179 | 28,645 | 22,094 | 24,574 | |||
| Liabilities, other than long-term debt | 4,907 | 7,768 | 10,099 | 10,144 | 7,124 | 6,962 | |||
| Accounts payable and accrued liabilities | 2,039 | 3,916 | 4,767 | 5,016 | 6,115 | 5,922 | |||
| Deferred income tax liabilities | 1,588 | 2,673 | 4,356 | ✕ | |||||
| Other liabilities | 1,280 | 1,179 | 976 | 5,128 | 1,009 | 1,040 | |||
| Other undisclosed noncurrent liabilities | |||||||||
| Total noncurrent liabilities: | 28,096 | 30,725 | 35,278 | 38,789 | 29,218 | 31,536 | |||
| Total liabilities: | 39,376 | 41,962 | 46,888 | 50,186 | 38,977 | 42,141 | |||
| Equity | |||||||||
| Equity, attributable to parent | 22,833 | 21,240 | 21,069 | 18,202 | 22,525 | 21,387 | |||
| Common stock | 1 | 1 | 1 | 1 | 1 | 1 | |||
| Additional paid in capital | 6,500 | 5,550 | 4,661 | 3,880 | 3,051 | 2,282 | |||
| Accumulated other comprehensive income (loss) | 28 | 2 | 83 | (60) | 85 | 80 | |||
| Retained earnings | 16,304 | 15,687 | 16,324 | 14,381 | 19,388 | 19,024 | |||
| Other undisclosed equity, attributable to parent | |||||||||
| Equity, attributable to noncontrolling interest | (84) | (31) | (5) | 19 | 125 | 147 | |||
| Other undisclosed equity | |||||||||
| Total equity: | 22,749 | 21,209 | 21,064 | 18,221 | 22,650 | 21,534 | |||
| TOTAL LIABILITIES AND EQUITY: | 62,125 | 63,171 | 67,952 | 68,407 | 61,627 | 63,675 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 27,116 | 27,281 | 27,305 | 24,689 | 22,449 | 22,127 | ||
| Cost of revenue | (6,498) | (5,657) | (6,601) | (4,572) | (4,675) | (4,853) | ||
| Cost of goods and services sold | (6,498) | (5,657) | (6,601) | (4,572) | (4,675) | (4,853) | ||
| Gross profit: | 20,618 | 21,624 | 20,704 | 20,117 | 17,774 | 17,274 | ||
| Operating expenses | (13,013) | (14,294) | (10,786) | (16,046) | (14,287) | (9,894) | ||
| Other undisclosed operating income | 800 | 820 | ||||||
| Operating income: | 7,605 | 7,330 | 9,918 | 4,071 | 4,287 | 8,200 | ||
| Nonoperating income (expense) | 198 | (581) | (639) | (1,418) | 1,868 | 676 | ||
| Investment income, nonoperating | 57 | 67 | 21 | (51) | 22 | (2) | ||
| Interest and debt expense | (944) | (935) | (1,001) | (984) | (995) | (1,077) | ||
| Income from continuing operations before income taxes: | 6,859 | 5,814 | 8,278 | 1,669 | 5,160 | 7,799 | ||
| Income tax expense (benefit) | (1,247) | (1,248) | (2,077) | (1,580) | 204 | (2,339) | ||
| Income from continuing operations: | 5,612 | 4,566 | 6,201 | 89 | 5,364 | 5,460 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 6,201 | 89 | 5,364 | 5,460 | |
| Other undisclosed net income | 1 | |||||||
| Net income: | 5,613 | 4,566 | 6,201 | 89 | 5,364 | 5,460 | ||
| Net income (loss) attributable to noncontrolling interest | 52 | 26 | 24 | 34 | 22 | (5) | ||
| Net income available to common stockholders, diluted: | 5,665 | 4,592 | 6,225 | 123 | 5,386 | 5,455 | ||
Comprehensive Income ($ in millions)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 5,613 | 4,566 | 6,201 | 89 | 5,364 | 5,460 | ||
| Other comprehensive income (loss) | 26 | (81) | 143 | (145) | 5 | 208 | ||
| Comprehensive income (loss): | 5,639 | 4,485 | 6,344 | (56) | 5,369 | 5,668 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 52 | 26 | 24 | 34 | 22 | (5) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | ||||||||
| Comprehensive income (loss), net of tax, attributable to parent: | 5,691 | 4,511 | 6,368 | (22) | 5,391 | 5,663 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.